Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma
Shailender Bhatia(University of Washington), Paul Nghiem(University of Washington Medical Center)
Cited by 89
Related Papers
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
|Journal for ImmunoTherapy of Cancer|2020|197
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses
|Journal for ImmunoTherapy of Cancer|2024|11